Statins and myotoxicity

Related Experiment Videos

John A Farmer1

  • 1Baylor College of Medicine, One Baylor Plaza, Room 525D, Houston, TX 77030, USA. jfarmer@bcm.tmc.edu

Current Atherosclerosis Reports
|February 8, 2003
PubMed

Insights

Statin therapy effectively reduces cardiovascular events but can cause muscle problems like myopathy. Further research is needed to understand the exact mechanisms of statin-associated muscle toxicity.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Cardiovascular mortality has declined significantly due to multiple factors.
  • Statin therapy has been crucial in managing dyslipidemia for patients at risk of coronary events.
  • Large-scale trials confirm statin efficacy in reducing cardiovascular morbidity and mortality.

Purpose of the Study:

  • To review the risk-benefit profile of statin therapy, focusing on muscle toxicity.
  • To clarify the relationship between statins and muscle-related adverse effects.
  • To explore potential mechanisms underlying statin-associated muscle toxicity.

Main Methods:

  • Analysis of data from large-scale statin mega-trials.
  • Review of histopathologic studies on statin-induced myopathy.
  • Examination of clinical risk-benefit data regarding reductase inhibitors.

Main Results:

  • Statin therapy is effective in primary and secondary cardiovascular prevention.
  • Muscle toxicity, including myopathy and myalgias with normal creatine kinase, is an identified risk.
  • Quantitative risk-benefit data from mega-trials have been clarified.

Conclusions:

  • While statins offer significant cardiovascular benefits, muscle toxicity is a recognized clinical risk.
  • The precise mechanisms of statin-associated muscle toxicity are not fully understood.
  • Potential contributing factors include genetic predispositions, drug interactions, metabolic alterations, and intrinsic drug properties.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...